Fresenius SE & Co KGaA
1FRE
Company Profile
Business description
Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
Contact
Else-Kroener-Strasse 1
Bad HomburgHE61352
DEUT: +49 61726080
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2025
Employees
175,202
Stocks News & Analysis
stocks
Ask the analyst: Are Qantas shares a value trap?
Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?
stocks
Palantir earnings: Blockbuster growth amid high expectations
We raise our fair value estimate off the back of earnings.
stocks
ResMed earnings: Solid showing from ASX healthcare winner
Strong demand growth and improved profit margins lead to a strong result from the sleep apnea device firm.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,111.10 | 82.30 | 0.91% |
CAC 40 | 7,635.03 | 13.99 | 0.18% |
DAX 40 | 23,924.36 | 78.29 | 0.33% |
Dow JONES (US) | 44,193.12 | 81.38 | 0.18% |
FTSE 100 | 9,164.31 | 21.58 | 0.24% |
HKSE | 24,910.63 | 8.10 | 0.03% |
NASDAQ | 21,169.42 | 252.87 | 1.21% |
Nikkei 225 | 40,794.86 | 245.32 | 0.60% |
NZX 50 Index | 12,924.03 | 43.87 | 0.34% |
S&P 500 | 6,345.06 | 45.87 | 0.73% |
S&P/ASX 200 | 8,843.70 | 73.30 | 0.84% |
SSE Composite Index | 3,633.99 | 16.40 | 0.45% |